Advanced Filter

Filter by Group

Filter by Market Availability

Displaying all 6 drugs
Epoetin Delta is an ingredient in the EMA-withdrawn product Dynepo.
Approved
Investigational
Withdrawn
Matched Synonyms: … Epoetin delta …
Matched Name: … Epoetin delta …
Matched Description: … Epoetin Delta is an ingredient in the EMA-withdrawn product Dynepo. …
Erythropoietin (EPO) is a growth factor produced in the kidneys that stimulates the production of red blood cells. It works by promoting the division and differentiation of committed erythroid progenitors in the bone marrow [FDA Label]. Epoetin alfa (Epoge) was developed by Amgen Inc. in 1983 as the first rhEPO...
Approved
Matched Synonyms: … Epoetinum zeta ... Epoetina alfa ... Epoetina beta …
Matched Description: … Epoetin alfa biosimilar, such as Retacrit (epoetin alfa-epbx or epoetin zeta), has been formulated to ... Epoetin alfa formulations can be administered intravenously or subcutaneously. ... Epoetin alfa (Epoge) was developed by Amgen Inc. in 1983 as the first rhEPO commercialized in the United …
Matched Products: … EPOETIN ALFA ... Epoetin Alfa Hexal ... EPOETIN ALFA HEXAL 1000IE …
Methoxy polyethylene glycol-epoetin beta is a chemically synthesised Erythropoiesis Stimulating Agent (ESA) with a longer half-life than erythropoietin. ESA is used to increase synthesis of red blood cells to treat chronic kidney disease associated anemia.
Approved
Matched Name: … Methoxy polyethylene glycol-epoetin beta …
Matched Description: … Methoxy polyethylene glycol-epoetin beta is a chemically synthesised Erythropoiesis Stimulating Agent …
Matched Categories: … methoxy polyethylene glycol-epoetin beta …
Efepoetin alfa is under investigation in clinical trial NCT04155125 (A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient).
Investigational
Matched Synonyms: … Human erythropoietin (epoetin alfa) fused to a hybrid human immunoglobulin (ig), consisting of the fc …
Luspatercept is a recombinant fusion protein comprised of a modified extracellular domain of activin receptor type IIB fused to the FC domain of human IgG1.[A187829,L42455] It was first approved for use in the United States in November 2019 under the brand name Reblozyl® for the treatment of anemia in patients...
Approved
Investigational
Matched Description: … erythropoiesis, in contrast to typical erythropoiesis-stimulating agents (ESAs), such as [darbepoetin alfa] and [epoetin
Sodium ferric gluconate complex is an iron replacement product for treatment of iron deficiency anemia. The stable macromolecular complex is negatively charged at alkaline pH with an apparent molecular weight of 289,000 – 440,000 daltons on gel chromatography. It is composed of iron (III) oxide hydrate directly bonded to sucrose...
Approved
Matched Description: … age of 6 years with chronic kidney disease (CKD) receiving hemodialysis and receiving supplemental epoetin
Displaying all 6 drugs